Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Cognitive Impairment in Parkinson's Disease
NCT01738191Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in cognitive impairment, sponsored by Medical University of South Carolina. Started Nov 2012; status: completed.
02
Drugs
atomoxetine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT01738191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738191.